JPWO2020154268A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020154268A5 JPWO2020154268A5 JP2021543226A JP2021543226A JPWO2020154268A5 JP WO2020154268 A5 JPWO2020154268 A5 JP WO2020154268A5 JP 2021543226 A JP2021543226 A JP 2021543226A JP 2021543226 A JP2021543226 A JP 2021543226A JP WO2020154268 A5 JPWO2020154268 A5 JP WO2020154268A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nucleic acid
- angptl7
- position corresponding
- acid molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024213170A JP2025023307A (ja) | 2019-01-23 | 2024-12-06 | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962795665P | 2019-01-23 | 2019-01-23 | |
| US62/795,665 | 2019-01-23 | ||
| US201962880609P | 2019-07-30 | 2019-07-30 | |
| US62/880,609 | 2019-07-30 | ||
| US201962902683P | 2019-09-19 | 2019-09-19 | |
| US62/902,683 | 2019-09-19 | ||
| US201962909573P | 2019-10-02 | 2019-10-02 | |
| US62/909,573 | 2019-10-02 | ||
| PCT/US2020/014373 WO2020154268A2 (en) | 2019-01-23 | 2020-01-21 | Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213170A Division JP2025023307A (ja) | 2019-01-23 | 2024-12-06 | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022523301A JP2022523301A (ja) | 2022-04-22 |
| JPWO2020154268A5 true JPWO2020154268A5 (https=) | 2023-01-30 |
| JP2022523301A5 JP2022523301A5 (https=) | 2023-01-30 |
Family
ID=69591771
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543226A Pending JP2022523301A (ja) | 2019-01-23 | 2020-01-21 | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
| JP2024213170A Pending JP2025023307A (ja) | 2019-01-23 | 2024-12-06 | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024213170A Pending JP2025023307A (ja) | 2019-01-23 | 2024-12-06 | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11767526B2 (https=) |
| EP (1) | EP3914711A2 (https=) |
| JP (2) | JP2022523301A (https=) |
| KR (1) | KR20210132045A (https=) |
| CN (1) | CN113646432A (https=) |
| AU (1) | AU2020210630C1 (https=) |
| CA (1) | CA3126476A1 (https=) |
| IL (1) | IL284700B2 (https=) |
| MX (1) | MX2021008797A (https=) |
| SG (1) | SG11202107497XA (https=) |
| WO (1) | WO2020154268A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11845989B2 (en) | 2019-01-23 | 2023-12-19 | Regeneron Pharmaceuticals, Inc. | Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors |
| JP2022523301A (ja) | 2019-01-23 | 2022-04-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
| KR20220024153A (ko) | 2019-05-24 | 2022-03-03 | 엠피리코 인크. | 안지오포이에틴 유사 7(angptl7) 관련 질환의 치료 |
| WO2022072356A1 (en) * | 2020-09-29 | 2022-04-07 | Empirico Inc. | Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases |
| EP4251753A4 (en) * | 2020-11-24 | 2025-08-06 | Empirico Inc | TREATMENT OF DISEASES AND DISORDERS RELATED TO SOS2 |
| WO2022182768A1 (en) * | 2021-02-26 | 2022-09-01 | Regeneron Pharmaceuticals, Inc. | Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors |
| EP4408535A1 (en) * | 2021-09-30 | 2024-08-07 | Regeneron Pharmaceuticals, Inc. | Treatment of glaucoma with rho guanine nucleotide exchange factor 12 (arhgef12) inhibitors |
| US20240409943A1 (en) * | 2021-10-01 | 2024-12-12 | Alnylam Pharmaceuticals, Inc. | iRNA Compositions and Methods for Targeting ANGPTL7 |
| IL313191A (en) * | 2021-12-22 | 2024-07-01 | Regeneron Pharma | Treatment of kidney diseases using angiopoietin-like inhibitors 3 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20171010T8 (hr) | 2004-08-23 | 2017-11-03 | Sylentis S.A.U. | Liječenje poremećaja očiju koji su karakterizirani povišenim intraokularnim pritiskom pomoću sirnk |
| US20100028875A1 (en) | 2006-07-05 | 2010-02-04 | Mun-Gan Rhyu | Method for diagnosing cancer by detecting the methylation of transitional zones |
| AU2010247800A1 (en) | 2009-05-11 | 2011-12-15 | Berg Llc | Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| CN102497884A (zh) | 2009-07-27 | 2012-06-13 | 巴克斯特国际公司 | 凝血蛋白缀合物 |
| KR101912335B1 (ko) | 2009-07-27 | 2018-10-26 | 리폭센 테크놀로지즈 리미티드 | 비혈액 응고 단백질의 글리코폴리시알화 |
| US8809501B2 (en) | 2009-07-27 | 2014-08-19 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| US8642737B2 (en) | 2010-07-26 | 2014-02-04 | Baxter International Inc. | Nucleophilic catalysts for oxime linkage |
| CN106110311A (zh) | 2009-07-27 | 2016-11-16 | 百深公司 | 凝血蛋白缀合物 |
| EP2494351B1 (en) | 2009-10-26 | 2016-06-08 | Externautics S.p.A. | Colon and rectal tumor markers and methods of use thereof |
| EP3178944B1 (en) | 2010-01-11 | 2019-05-15 | Genomic Health, Inc. | Method to use gene expression to determine likelihood of clinical outcome of renal cancer |
| EP2397559A1 (en) | 2010-06-17 | 2011-12-21 | Max-Delbrück-Centrum Für Molekulare Medizin | Stage-specific biomarkers for the diagnosis of acute kidney injury |
| US20120010230A1 (en) | 2010-07-08 | 2012-01-12 | Macdougall John R | Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| DK2598172T3 (da) | 2010-07-30 | 2019-07-01 | Baxalta GmbH | Nukleofile katalysatorer til oximforbindelse |
| HUE049352T2 (hu) | 2010-12-22 | 2020-09-28 | Baxalta GmbH | Anyagok és módszerek egy vízoldható zsírsavszármazéknak egy fehérjéhez való konjugálására |
| WO2012159084A1 (en) | 2011-05-18 | 2012-11-22 | Baxter International, Inc. | Modification-dependent activity assays |
| AU2012328524B2 (en) | 2011-10-28 | 2017-05-18 | Excelse Bio, Inc. | Protein formulations containing amino acids |
| WO2013120497A1 (en) | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
| US20130310546A1 (en) | 2012-05-16 | 2013-11-21 | Bater Healthcare Sa | Nucleophilic catalysts for oxime linkage and use of nmr analyses of the same |
| AU2013204754C1 (en) | 2012-05-16 | 2018-10-11 | Takeda Pharmaceutical Company Limited | Nucleophilic Catalysts for Oxime Linkage |
| US20150174203A1 (en) | 2012-05-30 | 2015-06-25 | Icahn School Of Medicine At Mount Sinai | Compositions And Methods For Modulating Pro-Inflammatory Immune Response |
| JP2016500512A (ja) | 2012-09-21 | 2016-01-14 | アンテグラジャンＩｎｔｅｇｒａｇｅｎ | 肝臓サンプルの分類ならびに限局性結節性異形成、肝細胞腺腫および肝細胞癌の診断のための新規方法 |
| US9206423B2 (en) | 2012-12-30 | 2015-12-08 | The Regents Of The University Of California | Methods of modulating compliance of the trabecular meshwork |
| WO2014167529A1 (en) | 2013-04-10 | 2014-10-16 | Institut De Cardiologie De Montreal | Methods and compositions for preventing and treating atherosclerosis |
| US10011837B2 (en) | 2014-03-04 | 2018-07-03 | Sylentis Sau | SiRNAs and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| KR20170007449A (ko) | 2014-05-22 | 2017-01-18 | 프레드 헛친슨 켄서 리서치 센터 | 조혈 전구체 세포의 lilrb2 및 노치 매개 증식 |
| EP3380611A4 (en) | 2015-11-24 | 2020-02-12 | Commonwealth Scientific and Industrial Research Organisation | PRODUCTION OF VIRUSES IN A CELL CULTURE |
| BR112018010503A2 (pt) | 2015-11-24 | 2018-11-13 | Commw Scient Ind Res Org | ovo de ave, método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, ave transgênica, e método para produzir uma ave |
| WO2017168348A1 (en) | 2016-03-31 | 2017-10-05 | Baylor Research Institute | Angiopoietin-like protein 8 (angptl8) |
| CN109844123A (zh) | 2016-08-19 | 2019-06-04 | 株式会社图尔金 | 经人工操纵的血管生成调控系统 |
| MA46089A (fr) * | 2016-08-30 | 2019-07-10 | Regeneron Pharma | Procédés de traitement de la résistance à l'insuline grave par interférence avec la signalisation du récepteur du glucagon |
| US12447213B2 (en) | 2016-10-07 | 2025-10-21 | The Broad Institute, Inc. | Modulation of novel immune checkpoint targets |
| JP2019535265A (ja) | 2016-11-14 | 2019-12-12 | メモリアル スローン ケタリング キャンサー センター | 幹細胞由来シュワン細胞 |
| WO2018174861A1 (en) | 2017-03-21 | 2018-09-27 | Mprobe Inc. | Methods and compositions for detecting early stage breast cancer with rna-seq expression profiling |
| JP2020514395A (ja) | 2017-03-23 | 2020-05-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 老化細胞および細胞老化関連分泌形質による発毛の刺激 |
| JP2018164442A (ja) * | 2017-03-28 | 2018-10-25 | 国立大学法人 熊本大学 | 皮膚有棘細胞癌の判定、予防又は治療方法 |
| JP6779164B2 (ja) * | 2017-03-28 | 2020-11-04 | ヤンマーパワーテクノロジー株式会社 | 作業車両の自律走行システム |
| CA3065317A1 (en) | 2017-05-31 | 2018-12-06 | Commonwealth Scientific And Industrial Research Organisation | Trait selection in avians |
| WO2019140380A1 (en) | 2018-01-12 | 2019-07-18 | Kymera Therapeutics, Inc. | Protein degraders and uses thereof |
| EP3740224A4 (en) | 2018-01-18 | 2022-05-04 | Adanate, Inc. | ANTI-LILRB ANTIBODIES AND THEIR USES |
| GB201806118D0 (en) | 2018-04-13 | 2018-05-30 | Univ Edinburgh | Macrophage use |
| JP2022523301A (ja) | 2019-01-23 | 2022-04-22 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アンジオポエチン様７（ａｎｇｐｔｌ７）阻害剤による眼疾患の治療 |
| KR20220024153A (ko) | 2019-05-24 | 2022-03-03 | 엠피리코 인크. | 안지오포이에틴 유사 7(angptl7) 관련 질환의 치료 |
| WO2022072356A1 (en) | 2020-09-29 | 2022-04-07 | Empirico Inc. | Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases |
-
2020
- 2020-01-21 JP JP2021543226A patent/JP2022523301A/ja active Pending
- 2020-01-21 AU AU2020210630A patent/AU2020210630C1/en active Active
- 2020-01-21 MX MX2021008797A patent/MX2021008797A/es unknown
- 2020-01-21 KR KR1020217026590A patent/KR20210132045A/ko active Pending
- 2020-01-21 WO PCT/US2020/014373 patent/WO2020154268A2/en not_active Ceased
- 2020-01-21 IL IL284700A patent/IL284700B2/en unknown
- 2020-01-21 SG SG11202107497XA patent/SG11202107497XA/en unknown
- 2020-01-21 CA CA3126476A patent/CA3126476A1/en active Pending
- 2020-01-21 EP EP20705596.3A patent/EP3914711A2/en active Pending
- 2020-01-21 CN CN202080022870.2A patent/CN113646432A/zh active Pending
- 2020-01-21 US US16/748,006 patent/US11767526B2/en active Active
-
2021
- 2021-05-12 US US17/318,023 patent/US11512309B2/en active Active
-
2024
- 2024-12-06 JP JP2024213170A patent/JP2025023307A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3693352B2 (ja) | プローブアレイを使用して、遺伝子多型性を検出し、対立遺伝子発現をモニターする方法 | |
| JP2008520242A5 (https=) | ||
| KR20170015509A (ko) | 담도암 검출 키트 또는 디바이스 및 검출 방법 | |
| WO2006126040A1 (en) | Bacterial and bacterial associated mirnas and uses thereof | |
| CN113046424B (zh) | 一种用于pcr检测的核酸组合物的制备方法及其制备的核酸组合物和pcr检测方法 | |
| JP2011505812A5 (https=) | ||
| WO2016167317A1 (ja) | 遺伝子変異の検出方法 | |
| US11591646B2 (en) | Small RNA detection method based on small RNA primed xenosensor module amplification | |
| WO2008064519A1 (en) | Methods and compositions for diagnosis of esophageal cancer and prognosis and improvement of patient survival | |
| US20080280843A1 (en) | Methods and kits for linking polymorphic sequences to expanded repeat mutations | |
| JPWO2020154268A5 (https=) | ||
| CN105506156B (zh) | 诊断骨肉瘤的分子标志物 | |
| Greber-Platzer et al. | Evidence against the current hypothesis of “gene dosage effects” of trisomy 21: ets-2, encoded on chromosome 21” is not overexpressed in hearts of patients with Down syndrome | |
| CN108796077B (zh) | 在cfDNA中检测胞嘧啶脱氨酶及相关分子基因修饰差异的引物对组及试剂盒 | |
| JP2005507654A5 (https=) | ||
| CN108676852B (zh) | 在外周血游离dna中检测p53基因表观遗传学修饰差异的引物对组及试剂盒 | |
| JP2024521754A5 (https=) | ||
| JP4145129B2 (ja) | Ｐｃｒクランピング法 | |
| JP5169306B2 (ja) | プロスタサイクリン受容体遺伝子のｓｎｐを利用した緑内障の発症リスクの判定方法 | |
| JP2022544393A (ja) | マクロファージ刺激１受容体（ｍｓｔ１ｒ）バリアント及びその使用 | |
| JPWO2020139830A5 (https=) | ||
| RU2023131494A (ru) | Лечение цереброваскулярного заболевания с помощью агентов - белков-гомологов 3 нейрогенного локуса notch (notch3) | |
| RU2021121850A (ru) | Лечение офтальмологических патологических состояний ингибиторами ангиопоэтин-подобного белка 7 (angptl7) | |
| CN108251519B (zh) | 轴前多指病的致病基因及其用途 | |
| RU2021122161A (ru) | Лечение респираторных нарушений с помощью ингибиторов арахидонат 15-липоксигеназы (alox15) |